Genome Editing


Genome editing with engineered nucleases (GEEN) is emergent type of Genetic Engineering. GEEN is the technology in which DNA is inserted, deleted or replaced in the genome. The emergence of highly versatile genome-editing technologies has provided investigators with the ability to rapidly and economically introduce sequence-specific modifications into the genomes of a broad spectrum of cell types and organisms. It also promotes various changes in sub cellular level. Genome Editing itself also holds tremendous potential for treating the underlying various idiopathic genetic causes of certain diseases. The core technologies now most commonly used techniques to facilitate genome editing are clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 9 (Cas9), transcription activator-like effector nucleases (TALENs), zinc-finger nucleases (ZFNs), and homing endonucleases or mega nucleases.


  • Stem cell and cellular therapies
  • Cell therapy: clinical trials

Related Conference of Genome Editing

May 03-04, 2023

16th World Congress on Stem Cell Research

Paris, France
May 03-04, 2023

Global Conference on Cell and Gene Therapy

Paris, France
June 08-09, 2023

10th World Congress on Epigenetics and Chromosome

Valencia, Spain
August 21-22, 2023

6th Annual Conference on Stem Cell and Regenerative Medicine

Frankfurt, Germany
September 25-26, 2023

19th Global Summit on Stem Cell & Regenerative Medicine

Zurich, Switzerland
October 19-20, 2023

5th Annual summit on Cell Signaling and Cancer Therapy

Montreal, Canada
November 08-09, 2023

4th Experts Meeting on Plant, Cellular and Molecular Biology

Budapest, Hungary
December 07-08, 2023

17th International Conference on Genomics & Pharmacogenomics

San Francisco, USA

Genome Editing Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in